The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Prognostic value of month 1 bone marrow and PET MRD status in CAR-T therapy for myeloma.
 
Radhika Bansal
No Relationships to Disclose
 
Jeffrey Babcock
No Relationships to Disclose
 
Larissa Brunaldi
No Relationships to Disclose
 
Saurabh Chhabra
Honoraria - GlaxoSmithKline; Janssen Oncology; Sanofi
Research Funding - C4 Therapeutics; CARsgen Therapeutics; Janssen
 
Ricardo Daniel Parrondo
No Relationships to Disclose
 
Morie A. Gertz
Honoraria - Abbvie; Akcea Therapeutics; Alnylam; Amgen; Apellis Pharmaceuticals; Celgene; Janssen Oncology; Juno/Celgene; Med Learning Group; Prothena; Research to Practice; Sanofi; Telix Pharmaceuticals
Consulting or Advisory Role - Bristol-Myers Squibb/Sanofi; Prothena
Travel, Accommodations, Expenses - Celgene; Novartis; Prothena
 
Matthew Hathcock
No Relationships to Disclose
 
David Dingli
No Relationships to Disclose
 
Prashant Kapoor
No Relationships to Disclose
 
Taxiarchis Kourelis
No Relationships to Disclose
 
Joselle Cook
No Relationships to Disclose
 
Suzanne R. Hayman
No Relationships to Disclose
 
Rahma M. Warsame
No Relationships to Disclose
 
Moritz Binder
No Relationships to Disclose
 
Rafael Fonseca
Stock and Other Ownership Interests - Adaptive Biotechnologies; Caris Life Sciences; OncoMyx Therapeutics
Honoraria - Abbvie; Aduro Biotech; Amgen; Bayer; Bristol-Myers Squibb; Celgene; Janssen; Juno Therapeutics; Kite, a Gilead company; Merck Sharp & Dohme; OncoTracker; Sanofi; Takeda
Consulting or Advisory Role - Abbvie; Aduro Biotech; Amgen; Bayer; Bristol-Myers Squibb; Celgene; GlaxoSmithKline; Janssen; Juno Therapeutics; Karyopharm Therapeutics; Kite, a Gilead company; Merck Sharp & Dohme; Oncopeptides; OncoTracker; Pfizer; Pharmacyclics; Regeneron; Sanofi; Takeda
Patents, Royalties, Other Intellectual Property - Dr Fonseca has received a patent for the prognostication of MM based on genetic categorization of the disease.
Travel, Accommodations, Expenses - Abbvie; Aduro Biotech; Amgen; Bayer; Bristol-Myers Squibb; Celgene; Janssen; Juno Therapeutics; Kite, a Gilead company; Merck Sharp & Dohme; OncoTracker; Sanofi; Takeda
Other Relationship - Adaptive Biotechnologies; Caris Life Sciences
 
Peter Leif Bergsagel
Consulting or Advisory Role - CellCentric; Janssen; Mundipharma; Salarius Pharmaceuticals
Research Funding - Pfizer (I)
Patents, Royalties, Other Intellectual Property - Mouse model of multiple myeloma
Travel, Accommodations, Expenses - Celgene
 
Sikander Ailawadhi
Consulting or Advisory Role - Amgen (Inst); Beigene; BMS (Inst); Cellectar (Inst); GlaxoSmithKline; Janssen (Inst); Pharmacyclics (Inst); Regeneron; Sanofi; Takeda
Research Funding - Abbvie (Inst); Amgen (Inst); Ascentage Pharma (Inst); BMS (Inst); Cellectar (Inst); GlaxoSmithKline (Inst); Janssen Biotech (Inst); MedImmune (Inst); Pharmacyclics (Inst); Sanofi (Inst); Xencor (Inst)
 
Shaji Kumar
Honoraria - BeiGene; Guangzhou Link Health Pharma; Secura Bio
Consulting or Advisory Role - Abbvie (Inst); Abbvie (Inst); Amgen (Inst); Bluebird Bio (Inst); Celgene (Inst); Genecentrix; Genentech/Roche (Inst); Janssen Oncology (Inst); Kite, a Gilead company (Inst); Molecular Partners (Inst); Oncopeptides; Takeda (Inst)
Research Funding - Abbvie (Inst); CARsgen Therapeutics (Inst); Celgene (Inst); Janssen Oncology (Inst); Kite, a Gilead company (Inst); MedImmune (Inst); Merck (Inst); Novartis (Inst); Roche/Genentech (Inst); Sanofi (Inst); Takeda (Inst); TeneoBio (Inst)
 
Stephen M Broski
No Relationships to Disclose
 
Yi Lin
Consulting or Advisory Role - Bluebird Bio (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Gamida Cell (Inst); Janssen Oncology (Inst); Juno Therapeutics (Inst); Kite/Gilead (Inst); Legend Biotech (Inst); Novartis (Inst); Pfizer (Inst); Sorrento Therapeutics (Inst); Vineti (Inst)
Research Funding - Bluebird Bio (Inst); Boston Scientific (Inst); Bristol-Myers Squibb (Inst); Janssen Oncology (Inst); Janssen Oncology (Inst); Kite/Gilead (Inst); Merck (Inst); Takeda (Inst)